Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001017491-13-000005
Filing Date
2013-11-12
Accepted
2013-11-12 16:10:55
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q apri-2013930x10q.htm 10-Q 813267
2 EX-31.1 apri-2013930xex311.htm EX-31.1 11511
3 EX-31.2 apri-2013930xex312.htm EX-31.2 11512
4 EX.32.1 apri-2013930xex321.htm EX-32.1 5271
5 EX-32.2 apri-2013930xex322.htm EX-32.2 5291
  Complete submission text file 0001017491-13-000005.txt   5953132

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT apri-20130930.xml EX-101.INS 667064
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT apri-20130930.xsd EX-101.SCH 48007
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT apri-20130930_cal.xml EX-101.CAL 91491
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT apri-20130930_def.xml EX-101.DEF 263339
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT apri-20130930_lab.xml EX-101.LAB 670363
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT apri-20130930_pre.xml EX-101.PRE 369730
Mailing Address 11975 EL CAMINO REAL, SUITE 300 SAN DIEGO, CA 92130
Business Address 11975 EL CAMINO REAL, SUITE 300 SAN DIEGO, CA 92130 (858) 222-8041
APRICUS BIOSCIENCES, INC. (Filer) CIK: 0001017491 (see all company filings)

EIN.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22245 | Film No.: 131210268
SIC: 2834 Pharmaceutical Preparations